Given the fact that disease knows no borders, public health matters are no longer domestic issues but worldwide tasks. The International Health Regulations 2005 (IHR 2005) was adopted after global SARS pandemic in 2003. Indonesia’s refuse for sharing H5N1 virus samples with WHO and global health community and its claim that virus sharing by developing countries and the benefit sharing after was imbalanced further promoted the adaptation of Pandemic Influenza Preparedness Framework-- for the sharing of influenza viruses and access to vaccines and other benefits (PIPF) in 2011. This framework not only regulated virus-sharing and benefit-sharing system, but also accomplished for equity by requiring industry contributions to WHO’s Global Influenza Surveillance and Response System (GISRS)’s operating costs. However, the preliminary Findings of review group in 2016 pointed out the limitation of the regulation as applied only for influenza, the lack of evaluation of effectiveness, the lack of regulation for Genetic Sequence Data and Partnership Contribution Fund, and the potential conflict with other international regulations such as Nagoya Protocol. While the final goal of PIP Framework is enhancing the global preparedness of infectious disease and serving as fundamental regulations for global health security, there is a strong need to analyze the development of PIP Framework and the harmonization of such a regulation with other international regulations. Therefore, this study aim at evaluating those important issues.
|Effective start/end date||8/1/17 → 7/31/18|